Clinical Trials Logo

Clinical Trial Summary

This longitudinal study deals with the characterization of the electrophysiological and behavioral effects of alpha-based neurofeedback training on the brain networks involved in the relaxation process of healthy people.


Clinical Trial Description

Despite a growing number of studies dedicated to neurofeedback, the underlying cerebral mechanisms (plasticity phenomena underlying neurofeedback training or learning) are very poorly known. In most of the work on stress and anxiety reduction, the neural parameters on which neurofeedback is performed are low frequency waves like alpha waves. But the effects that an alpha-based neurofeedback has on these waves and more generally on the oscillatory behaviour of the networks involved after the neurofeedback sessions, are very little studied.

Thus, the NEURORELAX study aims to clarify the effects on neurofeedback training at the (electro)physiological level (changes in brain responses in terms of frequency of oscillations, power and location of the cerebral sources of these activities) and/or behavioural level (relaxation and reduced susceptibility to anxiety). It will use the Melomind neurofeedback device as built by myBrain Technologies company, which will make it additionally possible to assess feasibility of neurofeedback training with this reduced mobile device comprising of 2 dry electrodes. For these purposes, the investigators will propose a series of auditory neurofeedback training sessions to the participants, accompanied by electrophysiological (EEG) and clinical measures. The level of relaxation of the subjects will be characterized by self-reported questionnaires and by electrophysiological signal measurement. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04545359
Study type Interventional
Source Centre National de la Recherche Scientifique, France
Contact Philippe Fossati, Pr
Phone +33 1 42 16 28 70
Email philippe.fossati@psl.aphp.fr
Status Recruiting
Phase N/A
Start date December 12, 2018
Completion date September 15, 2021

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05410795 - Establishment and Verification of Pancreatic Volume Formula Based on Imaging
Not yet recruiting NCT00966784 - The Effect of 2 Months Daily Supplementation of Orange Juice With Fibers Phase 1/Phase 2
Not yet recruiting NCT00966862 - The Glycemic Effect of Taking a Supplementation of Orange Juice With Fibers Phase 1/Phase 2
Recruiting NCT04213105 - Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Prolia® in Healthy Adults Phase 1
Completed NCT01840982 - The Effects of Mixed Grain on Blood Glucose and Insulin in Healthy Male N/A
Not yet recruiting NCT05619393 - Comparison of Kinematic Movements Between ACL Deficiency With ACL Reconstruction and Healthy People N/A
Recruiting NCT05095753 - Data Collection of Heart Rate and Blood Pressure
Enrolling by invitation NCT05140577 - Reliability and Validity of the Evaluation of Hip Abductors Strength (RAVEHABDS)
Completed NCT05888246 - Measuring the Range of Cardiac Magnetic Parameters in Healthy Subjects by Magnetocardiogram N/A
Not yet recruiting NCT04319211 - Effects of Social Isolation From Coronavirus; on Physical Activity, Quality of Life and Stress
Recruiting NCT01261195 - Establishment of Vascular Permeability Model for Research Purpose by Human Umbilical Vascular Endothelial Cells N/A
Not yet recruiting NCT01079585 - The Effect of 40gr Okara on Gastric Emptying N/A
Completed NCT01476865 - Articular Sonography: Healthy Subjects Versus Rheumatoid Arthritis Patients N/A
Not yet recruiting NCT01075568 - The Satiety Effect After Okara Compared to Porridge Eating N/A
Completed NCT04389255 - Developing a Balance Assessment System
Not yet recruiting NCT06303635 - Safety of UFRJvac, Trivalent COVID-19 Vaccine
Recruiting NCT03293056 - HIIH Versus HMC: Randomized Clinical Trial N/A
Not yet recruiting NCT06186635 - Comparison of Traditional and Artificial Intelligence-Assisted Yoga N/A
Not yet recruiting NCT06006182 - The Effects of Freeze-Dried Whole Grape Powder on Chronic Disease and Cardiovascular Risk Factors-a Pilot Study N/A
Completed NCT03651947 - Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Xgeva® in Healthy Adults Phase 1